BrightSpring Health Services, Inc.BTSG
ASignal's systematic analysis rates BTSG as Neutral.
Reflects the latest available analysis · analyzed Aug 27, 2026
The case on BTSG
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong year-over-year revenue growth (23.00%)
- Exceptional earnings growth (196.60% YoY)
- Free cash flow of $1.03B indicates solid cash generation
- Price near upper end of Bollinger Bands suggesting momentum
- RSI at 51.84 indicates neutral-to-bullish momentum, not overbought
- High P/E ratio (51.12x) relative to forward P/E (26.93x), suggesting valuation risk
- Debt-to-equity ratio of 1.16x indicates elevated leverage
- Low profit margins (net margin 2.55%, operating margin 3.37%)
- MACD below signal line despite small positive histogram, indicating weak momentum
- Price below 50-day SMA ($66.03) suggests short-term downtrend
See the full verdict on BTSG
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes BTSG
Most investors never get a second opinion, let alone several. ASignal runs BTSG past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.